May 2025

Cantoni at BioEquity Europe 2025 in Bruges

Cantoni Therapeutics will be present at BioEquity Europe in Bruges as part of our Series A fundraising activities. Connect with us to learn more about our exciting program, developing small molecule inhibitors of NNMT for the treatment of obesity and metabolic disease.

Back to news overview